Efficacy of Platelet Rich Plasma as Monotherapy in Treatment of Androgenetic Alopecia

The study aimed to evaluate the efficacy of platelet-rich plasma (PRP) as monotherapy for male androgenetic alopecia (MAA). A total of 20 male patients with MAA were treated with PRP injections into the scalp over a period of 3 months, with 6 sessions at 15-day intervals. Follow-up was conducted after 3 months, and the response to treatment was assessed using clinical photographs. At the end of the 6-month period, 18 out of 20 patients showed satisfactory hair growth, while 2 experienced a relapse. No side effects were reported, and all patients tolerated the procedure well. The study concluded that PRP is an affordable, effective, and promising therapy for androgenetic alopecia with no major adverse effects.